Nanostring Technologies
PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
SKU K130010UPC NYI
In Stock
—
IIFDA 510(k) Cleared (K130010)
1
Free shipping on orders over $99 · 30-day returns
Healix Assistant
Ask me anything about our products
Quick questions
Powered by Healix AI · Talk to a human
Nanostring Technologies
Free shipping on orders over $99 · 30-day returns
PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY is an FDA 510(k)-cleared medical device (K130010) manufactured by Nanostring Technologies. This device is classified under the Immunology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 5, 2013. Regulation: 8.
